المؤلفون: Beovic, B, Pulcini, C, Dumartin, C, Beraud, G, Nerat, B, Maurel, C, Dousak, M, Cizman, M

المصدر: International journal of antimicrobial agents. 52(5):616-621

مصطلحات موضوعية: Medicin och hälsovetenskap, Hälsovetenskap, Hälso- och sjukvårdsorganisation, hälsopolitik och hälsoekonomi, Klinisk medicin, Infektionsmedicin

URL الوصول: http://kipublications.ki.se/Default.aspx?queryparsed=id:139570885

المؤلفون: Furst, J, Cizman, M, Mrak, J, Kos, D, Campbell, S, Coenen, S, Gustafsson, LL, Furst, L, Godman, B

المصدر: Expert review of anti-infective therapy. 13(2):279-289

مصطلحات موضوعية: Medicin och hälsovetenskap

URL الوصول: http://kipublications.ki.se/Default.aspx?queryparsed=id:130609284

المؤلفون: Grigoryan, L, Haaijer-Ruskamp, FM, Burgerhof, JGM, Mechtler, R, Deschepper, R, Tambic-Andrasevic, A, Andrajati, R, Monnet, DL, Cunney, R, Di Matteo, A, Edelstein, H, Valinteliene, R, Alkerwi, A, Scicluna, EA, Grzesiowski, P, Bara, AC, Tesar, T, Cizman, M, Campos, J, Lundborg, CS, Birkin, J

المصدر: Emerging infectious diseases. 12(3):452-459

مصطلحات موضوعية: Medicin och hälsovetenskap

URL الوصول: http://kipublications.ki.se/Default.aspx?queryparsed=id:1947872

المؤلفون: Dyar, O.J., Beović, B., Pulcini, C., Tacconelli, E., Hulscher, M., Cookson, B., Ashiru-Oredope, D., Barcs, I., Blix, H.S., Buyle, F., Chowers, M., Čižman, M., Del Pozo, J.L., Deptula, A., Dumpis, U., Florea, D., van de Garde, E., Geffen, Y., Giske, C.G., Grau, S., Hajdú, E., Hell, M., Hondo, Ł., Hussein, K., Huttner, B., Kern, W., Kernéis, S., Knepper, V., Kofteridis, D., Kostyanev, T., Kuijper, E., Lebanova, H., Lewis, R., Cordina, C.M., Matulionyte, R., Maurer, F., Messiaen, P., Miciuleviciene, J., Mrhar, A., Nabuurs-Franssen, M., Naesens, R., Oxacelay, C., Pagani, L., Paño-Pardo, J.R., Paul, M., Petrikkos, G., Pluess-Suard, C., Popescu, G.A., Porsche, U.

المساهمون: ESCMID

المصدر: Clinical Microbiology and Infection ; volume 25, issue 1, page 13-19 ; ISSN 1198-743X

الاتاحة: http://dx.doi.org/10.1016/j.cmi.2018.09.022
https://api.elsevier.com/content/article/PII:S1198743X18306621?httpAccept=text/xml
https://api.elsevier.com/content/article/PII:S1198743X18306621?httpAccept=text/plain

المؤلفون: Cizman, M, Plankar Srovin, T

المصدر: GMS Infectious Diseases; VOL: 6; DOC05 /20180809/

مصطلحات موضوعية: ddc: 610

Relation: Ansari F, Molana H, Goossens H, Davey P; ESAC II Hospital Care Study Group. Development of standardized methods for analysis of changes in antibacterial use in hospitals from 18 European countries: the European Surveillance of Antimicrobial Consumption (ESAC) longitudinal survey, 2000-06. J Antimicrob Chemother. 2010 Dec;65(12):2685-91. DOI:10.1093/jac/dkq378; Ascioglu S, Samore MH, Lipsitch M. A new approach to the analysis of antibiotic resistance data from hospitals. Microb Drug Resist. 2014 Dec;20(6):583-90. DOI:10.1089/mdr.2013.0173; Austin DJ, Kristinsson KG, Anderson RM. The relationship between the volume of antimicrobial consumption in human communities and the frequency of resistance. Proc Natl Acad Sci U S A. 1999 Feb 2;96(3):1152-6.; Baym M, Stone LK, Kishony R. Multidrug evolutionary strategies to reverse antibiotic resistance. Science. 2016 Jan;351(6268):aad3292. DOI:10.1126/science.aad3292; Bell BG, Schellevis F, Stobberingh E, Goossens H, Pringle M. A systematic review and meta-analysis of the effects of antibiotic consumption on antibiotic resistance. BMC Infect Dis. 2014 Jan;14:13. DOI:10.1186/1471-2334-14-13; Bergman M, Huikko S, Huovinen P, Paakkari P, Seppälä H; Finnish Study Group for Antimicrobial Resistance (FiRe Network). Macrolide and azithromycin use are linked to increased macrolide resistance in Streptococcus pneumoniae. Antimicrob Agents Chemother. 2006 Nov;50(11):3646-50. DOI:10.1128/AAC.00234-06; Bronzwaer SL, Cars O, Buchholz U, Mölstad S, Goettsch W, Veldhuijzen IK, Kool JL, Sprenger MJ, Degener JE; European Antimicrobial Resistance Surveillance System. A European study on the relationship between antimicrobial use and antimicrobial resistance. Emerging Infect Dis. 2002 Mar;8(3):278-82. DOI:10.3201/eid0803.010192; Butler CC, Dunstan F, Heginbothom M, Mason B, Roberts Z, Hillier S, Howe R, Palmer S, Howard A. Containing antibiotic resistance: decreased antibiotic-resistant coliform urinary tract infections with reduction in antibiotic prescribing by general practices. Br J Gen Pract. 2007 Oct;57(543):785-92.; Cai T, Verze P, Brugnolli A, Tiscione D, Luciani LG, Eccher C, Lanzafame P, Malossini G, Wagenlehner FM, Mirone V, Bjerklund Johansen TE, Pickard R, Bartoletti R. Adherence to European Association of Urology Guidelines on Prophylactic Antibiotics: An Important Step in Antimicrobial Stewardship. Eur Urol. 2016 Feb;69(2):276-83. DOI:10.1016/j.eururo.2015.05.010; Center for Disease Control and Prevention. Antibiotic resistance threats in the United States 2013. Atlanta: Center for Disease Control and Prevention; 2013. Available from: https://www.cdc.gov/drugresistance/pdf/ar-threats-2013-508.pdf; Chaouch C, Hassairi A, Riba M, Boujaafar N. Relation entre la resistance bacterienne et la consummation des antibiotiques [Association between bacterial resistance and antimicrobial consumption]. Ann Biol Clin (Paris). 2014 Sep-Oct;72(5):555-60. DOI:10.1684/abc.2014.0981; Cizman M. The use and resistance to antibiotics in the community. Int J Antimicrob Agents. 2003 Apr;21(4):297-307. DOI:10.1016/S0924-8579(02)00394-1; Cizman M, Plankar Srovin T. Antibiotic consumption and resistance of gram-negative pathogens (collateral damage). In: Bjerklund Johansen TE, Wagenlehner FME, Cho YH, Matsumoto T, Krieger JN, Shoskes D, Naber KG, editors. Urogenital Infections and Inflammations. Duesseldorf: GMS; 2017-. DOI:10.5680/lhuii000029; Cizman M. Measurement units for antibiotic consumption in outpatients. J Antimicrob Chemother. 2014 Oct;69(10):2877-8. DOI:10.1093/jac/dku194; Coenen S, Gielen B, Blommaert A, Beutels P, Hens N, Goossens H. Appropriate international measures for outpatient antibiotic prescribing and consumption: recommendations from a national data comparison of different measures. J Antimicrob Chemother. 2014 Feb;69(2):529-34. DOI:10.1093/jac/dkt385; Costelloe C, Metcalfe C, Lovering A, Mant D, Hay AD. Effect of antibiotic prescribing in primary care on antimicrobial resistance in individual patients: systematic review and meta-analysis. BMJ. 2010 May;340:c2096. DOI:10.1136/bmj.c2096; Dan S, Shah A, Justo JA, Bookstaver PB, Kohn J, Albrecht H, Al-Hasan MN. Prediction of Fluoroquinolone Resistance in Gram-Negative Bacteria Causing Bloodstream Infections. Antimicrob Agents Chemother. 2016 Mar 25;60(4):2265-72. DOI:10.1128/AAC.02728-15; DRIVE-AB. Quality indicators & quantity metrics of antibiotic use. DRIVE-AB; 2014. Available from: http://drive-ab.eu/wp-content/uploads/2014/09/WP1A_Final-QMs-QIs_final.pdf; ECDC (European Centre for Disease Prevention and Control); EFSA (European Food Safety Authority); EMA (European Medicines Agency). ECDC/EFSA/EMA first joint report on the integrated analysis of the consumption of antimicrobial agents and occurrence of antimicrobial resistance in bacteria from humans and food-producing animals. EFSA Journal. 2015;13(1):4006. DOI:10.2903/j.efsa.2015.4006; Enne VI. Reducing antimicrobial resistance in the community by restricting prescribing: can it be done? J Antimicrob Chemother. 2010 Feb;65(2):179-82. DOI:10.1093/jac/dkp443; Enne VI, Livermore DM, Stephens P, Hall LM. Persistence of sulphonamide resistance in Escherichia coli in the UK despite national prescribing restriction. Lancet. 2001 Apr 28;357(9265):1325-8. DOI:10.1016/S0140-6736(00)04519-0; European Association of Urology. Guidelines. 2015 ed. Arnhem: European Association of Urology; 2015. Available from: http://uroweb.org/wp-content/uploads/EAU-Extended-Guidelines-2015-Edn.pdf; European Centre for Disease Prevention and Control. Antimicrobial resistance surveillance in Europe 2014. Annual Report of the European Antimicrobial Resistance Surveillance Network (EARS-Net). Stockholm: ECDC; 2015. Available from: https://ecdc.europa.eu/sites/portal/files/media/en/publications/Publications/antimicrobial-resistance-europe-2014.pdf; European Centre for Disease Prevention and Control. Point prevalence survey of healthcare-associated infections and antimicrobial use in European acute care hospitals. Stockholm: ECDC; 2013.; European Centre for Disease Prevention and Control. Antimicrobial resistance surveillance in Europe 2013. Annual Report of the European Antimicrobial Resistance Surveillance Network (EARS-Net). Stockholm: ECDC; 2014. Available from: https://ecdc.europa.eu/sites/portal/files/media/en/publications/Publications/antimicrobial-resistance-surveillance-europe-2013.pdf; Gerding DN, Larson TA. Aminoglycoside resistance in gram-negative bacilli during increased amikacin use. Comparison of experience in 14 United States hospitals with experience in the Minneapolis Veterans Administration Medical Center. Am J Med. 1985 Jul 15;79(1A):1-7.; Gravatt LA, Pakyz AL. Challenges in measuring antibiotic consumption. Curr Infect Dis Rep. 2013 Dec;15(6):559-63. DOI:10.1007/s11908-013-0374-9; Guo W, He Q, Wang Z, Wei M, Yang Z, Du Y, Wu C, He J. Influence of antimicrobial consumption on gram-negative bacteria in inpatients receiving antimicrobial resistance therapy from 2008-2013 at a tertiary hospital in Shanghai, China. Am J Infect Control. 2015 Apr;43(4):358-64. DOI:10.1016/j.ajic.2014.12.010; Gupta K, Hooton TM, Stamm WE. Isolation of fluoroquinolone-resistant rectal Escherichia coli after treatment of acute uncomplicated cystitis. J Antimicrob Chemother. 2005 Jul;56(1):243-6. DOI:10.1093/jac/dki169; Harbarth S, Harris AD, Carmeli Y, Samore MH. Parallel analysis of individual and aggregated data on antibiotic exposure and resistance in gram-negative bacilli. Clin Infect Dis. 2001 Nov;33(9):1462-8. DOI:10.1086/322677; Hillier S, Roberts Z, Dunstan F, Butler C, Howard A, Palmer S. Prior antibiotics and risk of antibiotic-resistant community-acquired urinary tract infection: a case-control study. J Antimicrob Chemother. 2007 Jul;60(1):92-9. DOI:10.1093/jac/dkm141; Holmes AH, Moore LS, Sundsfjord A, Steinbakk M, Regmi S, Karkey A, Guerin PJ, Piddock LJ. Understanding the mechanisms and drivers of antimicrobial resistance. Lancet. 2016 Jan 9;387(10014):176-87. DOI:10.1016/S0140-6736(15)00473-0; Hong T, Moland ES, Abdalhamid B, Hanson ND, Wang J, Sloan C, Fabian D, Farajallah A, Levine J, Thomson KS. Escherichia coli: development of carbapenem resistance during therapy. Clin Infect Dis. 2005 May;40(10):e84-6. DOI:10.1086/429822; Hsu LY, Tan TY, Tam VH, Kwa A, Fisher DA, Koh TH; Network for Antimicrobial Resistance Surveillance (Singapore). Surveillance and correlation of antibiotic prescription and resistance of Gram-negative bacteria in Singaporean hospitals. Antimicrob Agents Chemother. 2010 Mar;54(3):1173-8. DOI:10.1128/AAC.01076-09; Ibrahim OM, Polk RE. Benchmarking antimicrobial drug use in hospitals. Expert Rev Anti Infect Ther. 2012 Apr;10(4):445-57. DOI:10.1586/eri.12.18; Ibrahim OM, Polk RE. Antimicrobial use metrics and benchmarking to improve stewardship outcomes: methodology, opportunities, and challenges. Infect Dis Clin North Am. 2014 Jun;28(2):195-214. DOI:10.1016/j.idc.2014.01.006; Kern WV, Fellhauer M, Hug M, Hoppe-Tichy T, Först G, Steib-Bauert M, de With K. [Recent antibiotic use in German acute care hospitals - from benchmarking to improved prescribing and quality care]. Dtsch Med Wochenschr. 2015 Nov;140(23):e237-46. DOI:10.1055/s-0041-105938; Lafaurie M, Porcher R, Donay JL, Touratier S, Molina JM. Reduction of fluoroquinolone use is associated with a decrease in methicillin-resistant Staphylococcus aureus and fluoroquinolone-resistant Pseudomonas aeruginosa isolation rates: a 10 year study. J Antimicrob Chemother. 2012 Apr;67(4):1010-5. DOI:10.1093/jac/dkr555; Livermore DM. Minimising antibiotic resistance. Lancet Infect Dis. 2005 Jul;5(7):450-9. DOI:10.1016/S1473-3099(05)70166-3; Livermore DM, Hope R, Reynolds R, Blackburn R, Johnson AP, Woodford N. Declining cephalosporin and fluoroquinolone non-susceptibility among bloodstream Enterobacteriaceae from the UK: links to prescribing change? J Antimicrob Chemother. 2013 Nov;68(11):2667-74. DOI:10.1093/jac/dkt212; McClean P, Hughes C, Tunney M, Goossens H, Jans B, European Surveillance of Antimicrobial Consumption (ESAC) Nursing Home Project Group. Antimicrobial prescribing in European nursing homes. J Antimicrob Chemother. 2011 Jul;66(7):1609-16. DOI:10.1093/jac/dkr183; Meyer E, Gastmeier P, Deja M, Schwab F. Antibiotic consumption and resistance: data from Europe and Germany. Int J Med Microbiol. 2013 Aug;303(6-7):388-95. DOI:10.1016/j.ijmm.2013.04.004; Milatovic D, Braveny I. Development of resistance during antibiotic therapy. Eur J Clin Microbiol. 1987 Jun;6(3):234-44.; Moher D, Liberati A, Tetzlaff J, Altman DG; PRISMA Group. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med. 2009 Jul 21;6(7):e1000097. DOI:10.1371/journal.pmed.1000097; Muller A, Monnet DL, Talon D, Hénon T, Bertrand X. Discrepancies between prescribed daily doses and WHO defined daily doses of antibacterials at a university hospital. Br J Clin Pharmacol. 2006 May;61(5):585-91. DOI:10.1111/j.1365-2125.2006.02605.x; Ortega M, Marco F, Soriano A, Almela M, Martínez JA, Muñoz A, Mensa J. Analysis of 4758 Escherichia coli bacteraemia episodes: predictive factors for isolation of an antibiotic-resistant strain and their impact on the outcome. J Antimicrob Chemother. 2009 Mar;63(3):568-74. DOI:10.1093/jac/dkn514; Paterson DL. "Collateral damage" from cephalosporin or quinolone antibiotic therapy. Clin Infect Dis. 2004 May;38 Suppl 4:S341-5. DOI:10.1086/382690; Peterson LR. Squeezing the antibiotic balloon: the impact of antimicrobial classes on emerging resistance. Clin Microbiol Infect. 2005 Oct;11 Suppl 5:4-16. DOI:10.1111/j.1469-0691.2005.01238.x; Péchère JC. Antibiotic resistance is selected primarily in our patients. Infect Control Hosp Epidemiol. 1994 Jul;15(7):472-7.; Plüss-Suard C, Pannatier A, Kronenberg A, Mühlemann K, Zanetti G. Impact of antibiotic use on carbapenem resistance in Pseudomonas aeruginosa: is there a role for antibiotic diversity? Antimicrob Agents Chemother. 2013 Apr;57(4):1709-13. DOI:10.1128/AAC.01348-12; Roca I, Akova M, Baquero F, Carlet J, Cavaleri M, Coenen S, Cohen J, Findlay D, Gyssens I, Heuer OE, Kahlmeter G, Kruse H, Laxminarayan R, Liébana E, López-Cerero L, MacGowan A, Martins M, Rodríguez-Baño J, Rolain JM, Segovia C, Sigauque B, Tacconelli E, Wellington E, Vila J. The global threat of antimicrobial resistance: science for intervention. New Microbes New Infect. 2015 Jul;6:22-9. DOI:10.1016/j.nmni.2015.02.007; Sarma JB, Marshall B, Cleeve V, Tate D, Oswald T, Woolfrey S. Effects of fluoroquinolone restriction (from 2007 to 2012) on resistance in Enterobacteriaceae: interrupted time-series analysis. J Hosp Infect. 2015 Sep;91(1):68-73. DOI:10.1016/j.jhin.2015.05.006; Schechner V, Temkin E, Harbarth S, Carmeli Y, Schwaber MJ. Epidemiological interpretation of studies examining the effect of antibiotic usage on resistance. Clin Microbiol Rev. 2013 Apr;26(2):289-307. DOI:10.1128/CMR.00001-13; Sedláková MH, Urbánek K, Vojtová V, Suchánková H, Imwensi P, Kolár M. Antibiotic consumption and its influence on the resistance in Enterobacteriaceae. BMC Res Notes. 2014 Jul;7:454. DOI:10.1186/1756-0500-7-454; Stewardson AJ, Gaa N, François P, Malhotra-Kumar S, Delémont C, Martinez de Tejada B, Schrenzel J, Harbarth S, Lazarevic V; SATURN WP1 and WP3 Study Groups. Collateral damage from oral ciprofloxacin versus nitrofurantoin in outpatients with urinary tract infections: a culture-free analysis of gut microbiota. Clin Microbiol Infect. 2015 Apr;21(4):344.e1-11. DOI:10.1016/j.cmi.2014.11.016; Sundqvist M, Geli P, Andersson DI, Sjölund-Karlsson M, Runehagen A, Cars H, Abelson-Storby K, Cars O, Kahlmeter G. Little evidence for reversibility of trimethoprim resistance after a drastic reduction in trimethoprim use. J Antimicrob Chemother. 2010 Feb;65(2):350-60. DOI:10.1093/jac/dkp387; Voor In 't Holt AF, Severin JA, Lesaffre EM, Vos MC. A systematic review and meta-analyses show that carbapenem use and medical devices are the leading risk factors for carbapenem-resistant Pseudomonas aeruginosa. Antimicrob Agents Chemother. 2014 May;58(5):2626-37. DOI:10.1128/AAC.01758-13; van de Sande-Bruinsma N, Grundmann H, Verloo D, Tiemersma E, Monen J, Goossens H, Ferech M; European Antimicrobial Resistance Surveillance System Group; European Surveillance of Antimicrobial Consumption Project Group. Antimicrobial drug use and resistance in Europe. Emerging Infect Dis. 2008 Nov;14(11):1722-30. DOI:10.3201/eid1411.070467; van der Starre WE, van Nieuwkoop C, Paltansing S, van't Wout JW, Groeneveld GH, Becker MJ, Koster T, Wattel-Louis GH, Delfos NM, Ablij HC, Leyten EM, Blom JW, van Dissel JT. Risk factors for fluoroquinolone-resistant Escherichia coli in adults with community-onset febrile urinary tract infection. J Antimicrob Chemother. 2011 Mar;66(3):650-6. DOI:10.1093/jac/dkq465; Wagenlehner FM, Bartoletti R, Cek M, Grabe M, Kahlmeter G, Pickard R, Bjerklund-Johansen TE. Antibiotic stewardship: a call for action by the urologic community. Eur Urol. 2013 Sep;64(3):358-60. DOI:10.1016/j.eururo.2013.05.044; WHO Collaborating Centre for Drug Statistic Methodology. Guidelines for ATC classification and DDD assignment 2016. Oslo: WHO Collaborating Centre for Drug Statistics Methodology; 2016.; Zemkova M, Kotlarova J, Merka V, Cermak P, Vlcek J, Jebavy L. Emergence of fluoroquinolone resistance in Escherichia coli isolates at the department of clinical hematology. New Microbiol. 2007 Oct;30(4):423-30.; Zou YM, Ma Y, Liu JH, Shi J, Fan T, Shan YY, Yao HP, Dong YL. Trends and correlation of antibacterial usage and bacterial resistance: time series analysis for antibacterial stewardship in a Chinese teaching hospital (2009-2013). Eur J Clin Microbiol Infect Dis. 2015 Apr;34(4):795-803. DOI:10.1007/s10096-014-2293-6; http://dx.doi.org/10.3205/id000040; http://nbn-resolving.de/urn:nbn:de:0183-id0000404; http://www.egms.de/en/journals/id/2018-6/id000040.shtml

الاتاحة: https://doi.org/10.3205/id000040
http://nbn-resolving.de/urn:nbn:de:0183-id0000404
http://www.egms.de/en/journals/id/2018-6/id000040.shtml

المؤلفون: Mitja Vrdelja, Tina Plankar Srovin, Tom Bajec, Rok Blagus, Cizman M, Bojana Beović

المصدر: Journal of Antimicrobial Chemotherapy. 73:2567-2572

مصطلحات موضوعية: 0301 basic medicine, Microbiology (medical), Attitude of Health Personnel, medicine.drug_class, Slovenia, 030106 microbiology, Antibiotics, Psychological intervention, 03 medical and health sciences, 0302 clinical medicine, Antibiotic resistance, Anatomical therapeutic chemical, Environmental health, Drug Resistance, Bacterial, Outpatients, Humans, Medicine, Pharmacology (medical), 030212 general & internal medicine, Medical prescription, Public awareness, Pharmacology, Consumption (economics), Inpatients, Bacteria, business.industry, Interrupted Time Series Analysis, Bacterial Infections, Awareness, Drug Utilization, Anti-Bacterial Agents, Penicillin, Infectious Diseases, business, medicine.drug

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e6065084f9b40d9d37933a04d5168c7f
https://doi.org/10.1093/jac/dky206

المؤلفون: Cizman, M.

المصدر: Journal of Antimicrobial Chemotherapy ; volume 66, issue 9, page 2189-2191 ; ISSN 0305-7453 1460-2091

الاتاحة: https://doi.org/10.1093/jac/dkr263
http://academic.oup.com/jac/article-pdf/66/9/2189/2308983/dkr263.pdf

المؤلفون: Beović, B., Kreft, S., Seme, K., Čižman, M.

المصدر: Journal of Chemotherapy ; volume 23, issue 4, page 216-220 ; ISSN 1120-009X 1973-9478

الاتاحة: http://dx.doi.org/10.1179/joc.2011.23.4.216
http://www.tandfonline.com/doi/pdf/10.1080/10256018808623883

المؤلفون: Kastrin, T., Paragi, M., Kolman, J., Čižman, M., Kraigher, A., Gubina, M.

المساهمون: Department of Medical Microbiology, National Institute of Public Health, Centre for Communicable Diseases, Department of Infectious Diseases, University Medical Centre Ljubljana Ljubljana, Slovenia (UMCL), School of Health Science, Higher Education Centre Novo mesto

المصدر: ISSN: 0934-9723.

مصطلحات موضوعية: Life Sciences

Relation: hal-00578456; https://hal.science/hal-00578456; https://hal.science/hal-00578456/document; https://hal.science/hal-00578456/file/PEER_stage2_10.1007%252Fs10096-010-0910-6.pdf

الاتاحة: https://hal.science/hal-00578456
https://hal.science/hal-00578456/document
https://hal.science/hal-00578456/file/PEER_stage2_10.1007%252Fs10096-010-0910-6.pdf
https://doi.org/10.1007/s10096-010-0910-6

المؤلفون: Zarb, P., Amadeo, B., Muller, A., Drapier, N., Vankerckhoven, V., Davey, P., Goossens, H., Metz-Gercek, S., Jansens, H., Markova, B., Kontemeniotou, C., Andrasevic, A., Vlcek, J., Frimodt-Moller, N., Mitt, P., Lyytikainen, O., Bertrand, X., de With, K., Antoniadou, A., Ternak, G., Cunney, R., Raz, R., Brusaferro, S., Dumpis, U., Butkyte, V., Marcel, B., Haug, J. B., Pawlowksa, J., Teixeira, I., Ratchina, S., Cizman, M., Sora, M., Skoog, G., Zanetti, G., Filius, M., Sardan, Y. C., Cooke, J., Webb, H., Heginbothom, M.

المصدر: Journal of Antimicrobial Chemotherapy ; volume 66, issue 2, page 443-449 ; ISSN 0305-7453 1460-2091

الاتاحة: http://dx.doi.org/10.1093/jac/dkq430
http://academic.oup.com/jac/article-pdf/66/2/443/2131604/dkq430.pdf

المؤلفون: Kastrin, T., Gubina, M., Paragi, M., Kolman, J., Cizman, M., Kraigher, A., Ribic, H., Sadowy, E., Hryniewicz, W.

المصدر: Journal of Antimicrobial Chemotherapy ; volume 62, issue 3, page 628-629 ; ISSN 0305-7453 1460-2091

مصطلحات موضوعية: Infectious Diseases, Pharmacology (medical), Pharmacology, Microbiology (medical)

الاتاحة: http://dx.doi.org/10.1093/jac/dkn202
http://academic.oup.com/jac/article-pdf/62/3/628/2179975/dkn202.pdf

المؤلفون: Beovic, B., Kreft, S., Seme, K., Cizman, M.

المصدر: International Journal of Infectious Diseases ; volume 12, page e362-e363 ; ISSN 1201-9712

الاتاحة: http://dx.doi.org/10.1016/j.ijid.2008.05.964
https://api.elsevier.com/content/article/PII:S1201971208010953?httpAccept=text/xml
https://api.elsevier.com/content/article/PII:S1201971208010953?httpAccept=text/plain

المؤلفون: Groselj Grenc, M., Derganc, M., Trsinar, B., Cizman, M.

المصدر: Journal of Chemotherapy ; volume 18, issue 1, page 38-42 ; ISSN 1120-009X 1973-9478

الاتاحة: http://dx.doi.org/10.1179/joc.2006.18.1.38
http://www.tandfonline.com/doi/pdf/10.1080/10256018808623883

المؤلفون: Cizman, M., Srovin, T., Pokorn, M., Cad Pecar, S., Battelino, S.

مصطلحات موضوعية: Original articles

وصف الملف: text/html

Relation: http://jac.oxfordjournals.org/cgi/content/short/55/5/758; http://dx.doi.org/10.1093/jac/dki098

الاتاحة: http://jac.oxfordjournals.org/cgi/content/short/55/5/758
https://doi.org/10.1093/jac/dki098

المؤلفون: Cizman, M.

المصدر: Journal of Antimicrobial Chemotherapy ; volume 49, issue 3, page 582-584 ; ISSN 1460-2091

الاتاحة: https://doi.org/10.1093/jac/49.3.582
http://academic.oup.com/jac/article-pdf/49/3/582/9843112/490582.pdf

المؤلفون: Cizman, M.

المصدر: Journal of Antimicrobial Chemotherapy ; volume 47, issue 4, page 475-477 ; ISSN 1460-2091

الاتاحة: https://doi.org/10.1093/jac/47.4.475
http://academic.oup.com/jac/article-pdf/47/4/475/9841526/470475.pdf

المؤلفون: Cizman, M.

المصدر: Journal of Antimicrobial Chemotherapy ; volume 47, issue 4, page 502-502 ; ISSN 1460-2091

مصطلحات موضوعية: Infectious Diseases, Pharmacology (medical), Pharmacology, Microbiology (medical)

الاتاحة: http://dx.doi.org/10.1093/jac/47.4.502
http://academic.oup.com/jac/article-pdf/47/4/502/9841535/470502.pdf

المؤلفون: Hufnagel M, Versporten A, Bielicki J, Drapier N, Sharland M, Goossens H, ARPEC Project Group, Omar A, Azmi AAMA, Martinot A, Tagarro A, Johnson A, Bustinza A, Amina AJ, Brett A, Andrea LV, Lunn A, Dramowski A, McCorry A, Enimil A, Rashed AN, Soto B, Santiago B, McCullagh B, Gormley C, Giaquinto C, Lozano CAG, Montagnani C, Briquet C, Cooper C, Centenari C, Barton C, Blyth CC, Nash C, Calvo C, Orbach D, Sharpe D, Gkentzi D, Robbrecht D, Kalavalapalli DB, Mozgis D, Tamm E, Cox E, Critselis E, Borgia E, Iosifidis E, Bell E, Roilides E, Menson E, Ladomenou F, Rodrigues F, Gahleitner F, Tavchioska G, Garg G, Syridou G, Pouladfar G, Nicolini G, Finlayson H, Jansens H, Sviestina I, Esteves I, Abubakar I, Soltani J, AlAjmi JA, Alsalman J, Aston J, Nielsen JP, Petersen JR, Liese J, Alexander J, Francis JR, Garrahan JP, Clark J, Pagava K, Mougkou K, Doerholt K, Marques L, Jensen LH, Renner L, Mahieu L, Galli L, Raka L, Pluta M, Heginbothom M, Luca M, Matsinen M, Raman M, Malviya M, Awunyo M, Laan M, Knuf M, Cancino ME, Isa MS, Lorrot M, Garbash M, Borg MA, Kler N, Caldwell NA, Spyridis N, Ureta N, McMaster P, Garg P, Gabriels P, Rossom PV, Barrero PT, Najdenov P, Zarb P, Lepage P, Maton P, Poorisrisak P, Satodia P, Howe R, Gupta R, Olivier R, Tenconi R, Singh S, Chan SM, Unuk S, Burokiene S, Drysdale SB, Cambrea SC, Kouni S, Blumental S, Murki S, Kohlhoff S, Schlag SAA, Sahu S, Esposito S, Luck S, Kovacevic T, Singhal T, Zaoutis T, Scorrer T, Rajagopal V, Gajdos V, Usonis V, Vandewal W, Jafarpour Z, Maskari ZA, Rubic Z, Hargadon-Lowe A, Rincon-Lopez EM, Al-Mousa H, Maté-Cano I, Saavedra-Lozano J, Rummukainen ML, Prot-Labarthe S, Arenas-Lopez S, Escosa-García L, Dona' D, Le Maréchal F, Čižman M, Castañon PZ, D'Argenio P

المساهمون: Hufnagel, M, Versporten, A, Bielicki, J, Drapier, N, Sharland, M, Goossens, H, ARPEC Project, Group, Omar, A, Azmi, Aama, Martinot, A, Tagarro, A, Johnson, A, Bustinza, A, Amina, Aj, Brett, A, Andrea, Lv, Lunn, A, Dramowski, A, Mccorry, A, Enimil, A, Rashed, An, Soto, B, Santiago, B, Mccullagh, B, Gormley, C, Giaquinto, C, Lozano, Cag, Montagnani, C, Briquet, C, Cooper, C, Centenari, C, Barton, C, Blyth, Cc, Nash, C, Calvo, C, Orbach, D, Sharpe, D, Gkentzi, D, Robbrecht, D, Kalavalapalli, Db, Mozgis, D, Tamm, E, Cox, E, Critselis, E, Borgia, E, Iosifidis, E, Bell, E, Roilides, E, Menson, E, Ladomenou, F, Rodrigues, F, Gahleitner, F, Tavchioska, G, Garg, G, Syridou, G, Pouladfar, G, Nicolini, G, Finlayson, H, Jansens, H, Sviestina, I, Esteves, I, Abubakar, I, Soltani, J, Alajmi, Ja, Alsalman, J, Aston, J, Nielsen, Jp, Petersen, Jr, Liese, J, Alexander, J, Francis, Jr, Garrahan, Jp, Clark, J, Pagava, K, Mougkou, K, Doerholt, K, Marques, L, Jensen, Lh, Renner, L, Mahieu, L, Galli, L, Raka, L, Pluta, M, Heginbothom, M, Luca, M, Matsinen, M, Raman, M, Malviya, M, Awunyo, M, Laan, M, Knuf, M, Cancino, Me, Isa, M, Lorrot, M, Garbash, M, Borg, Ma, Kler, N, Caldwell, Na, Spyridis, N, Ureta, N

مصطلحات موضوعية: Antimicrobial, Inpatient, Pediatric, Point-prevalence survey, Prophylactic prescribing

وصف الملف: STAMPA

Relation: info:eu-repo/semantics/altIdentifier/pmid/29579259; info:eu-repo/semantics/altIdentifier/wos/WOS:000472809600008; volume:8; issue:2; firstpage:143; lastpage:151; journal:JOURNAL OF THE PEDIATRIC INFECTIOUS DISEASES SOCIETY; http://hdl.handle.net/11391/1432599; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85065930800; http://jpids.oxfordjournals.org/

الاتاحة: http://hdl.handle.net/11391/1432599
https://doi.org/10.1093/jpids/piy019
http://jpids.oxfordjournals.org/

المؤلفون: Bielicki, J. A., Sharland, M., Johnson, A. P., Henderson, K. L., Cromwell, D. A., Berger, C., Esposito, Susanna Maria Roberta, Danieli, E., Tenconi, R., Folgori, L., Bernaschi, P., Santiago, B., Saavedra, J., Cercenado, E., Brett, A., Rodrigues, F., Cizman, M., Jazbec, J., Babnik, J., Pavčnik, M., Pirš, M., Mueller Premrov, M., Lindner, M., Borte, M., Lippmann, N., Schuster, V., Thürmer, A., Lander, F., Elias, J., Liese, J., Durst, A., Weichert, S., Schneider, C., Hufnagel, M., Rack, A., Hübner, J., Dubos, F., Lagree, M., Dessein, R., Tissieres, P., Cuzon, G., Gajdos, V., Doucet Populaire, F., Usonis, V., Gurksniene, V., Bernatoniene, G., Tsolia, M., Spyridis, N., Lebessi, E., Doudoulakakis, A., Lutsar, I., Kõljalg, S., Schülin, T., Warris, A.

المصدر: Journal of Antimicrobial Chemotherapy. 71:794-802

مصطلحات موضوعية: Male, 0301 basic medicine, Microbiology (medical), medicine.medical_specialty, Adolescent, 030106 microbiology, MEDLINE, Bacteremia, Microbial Sensitivity Tests, Drug resistance, Decision Support Techniques, 03 medical and health sciences, Bayes' theorem, pharmacology, pharmacology (medical), infectious diseases, 0302 clinical medicine, Antibiotic resistance, 030225 pediatrics, Humans, Medicine, Pharmacology (medical), Medical prescription, Child, Intensive care medicine, Pharmacology, Bacteria, business.industry, Incidence, Incidence (epidemiology), Infant, Newborn, Infant, Bayes Theorem, medicine.disease, Anti-Bacterial Agents, Regimen, Infectious Diseases, Child, Preschool, Epidemiological Monitoring, Emergency medicine, Female, business

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a11d835354a6db6f2315d89468dc5050
https://doi.org/10.1093/jac/dkv397

المؤلفون: Spyridis, N., Syridou, G., Goossens, H., Versporten, A., Kopsidas, J., Kourlaba, G., Bielicki, J., Drapier, N., Zaoutis, T., Tsolia, M., Sharland, M., Vergison, A., Leon, V., Delestrait, M., Huza, C., Lepage, P., Mahieu, L., Boy, T., Jansens, H., Van Der Linden, D., Briquet, C., Allegaert, K., Smits, A., Gabriels, P., Vuye, A., Lutsar, I., Tamm, E., Larionova, A., Laan, D., Orbach, M., Lorrot, M., Angoulvant, F., Prot-Labarthe, S., Dubos, F., Lagree, M., Hufnagel, M., Schuster, K., Henneke, P., Roilides, E., Iosifidis, E., Corovessi, V., Michos, A., Galanakis, E., Gkentzi, D., Giacquinto, C., Longo, G., Dona', D., Mion, T., D'Argenio, P., Degli, M. L. C., De Luca, M., Ciliento, G., Esposito, S., Danieli, E., Montinaro, V., Tenconi, R., Nicolini, G., Sviestina, C. I. M., Pavare, J., Rasnaca, K., Gardovska, D., Usonis, V., Grope, I., Gurksniene, V., Eidukaite, A., Biver, A., Brett, A., Esteves, I., Cambrea, S. C., Craiu, M., Tomescu, E., Cizman, M., Babnik, J., Kenda, R., Vidmar, I., Nunez-Cuadros, E., Rojo, P., Lopez-Varela, E., Ureta, N., Perez-Lopez, A., Mosqueda, R., Orta, L., Santos, M., Navarro, M., Santiago, B., Hernandez-Sampelaya, T., Saavedra, J., Pineiro, R., Torel, P., Cano, I. M., Baumann, P., Berger, C., Menson, E., Botgros, A., Doerholt, K., Drysdale, S., Makwana, N., Mccorry, A., Garbash, E. M., Chetcutiganado, C., Mcleod, M., Caldwell, N., Nash, C., Mccullagh, B., Sharpe, D., Tweddell, L., Liese, J. G., Aston, J., Gallagher, A., Satodia, P., Howard-Smith, N., Korinteli, I., Tavchioska, G., Jensen, L., Trethon, A., Unuk, S., Childs, N., Canlas, J.

المساهمون: Mahieu, Ludo, ARPEC Project Grp

المصدر: Archives of disease in childhood

مصطلحات موضوعية: Pediatrics, practice guidelines as topic, Antibiotics, cross-sectional studies, respiratory tract infections, sepsis, 0302 clinical medicine, newborn, Medicine, 030212 general & internal medicine, Practice Patterns, Physicians', humans, European paediatric hospitals, antibiotic guidelines, childhood infection, anti-bacterial agents, bacterial infections, child, preschool, drug administration schedule, drug prescriptions, Europe, hospitals, pediatric, infant, practice patterns, physicians', urinary tract infections, pediatrics, perinatology and child health, Antistaphylococcal penicillins, Respiratory tract infections, Neonatal sepsis, Hospitals, Pediatric, Child, Preschool, medicine.drug, medicine.medical_specialty, medicine.drug_class, Sepsis, 03 medical and health sciences, 030225 pediatrics, Internal medicine, business.industry, Infant, Newborn, Guideline, Amoxicillin, medicine.disease, Penicillin, Pediatrics, Perinatology and Child Health, Human medicine, business

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0f2fd4ff261a9f566828ae2cad285d11
https://doi.org/10.1136/archdischild-2015-308255